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ABSTRACT
Objectives To explore potential associations between 
vitamin D status and risk of chronic low back pain 
(LBP) in a Norwegian cohort, and to investigate whether 
relationships depend on the season of blood sample 
collection.
Design A nested case–control study in a prospective data 
set.
Setting The Norwegian community-based Nord-Trøndelag 
Health Study (HUNT). Data were collected in the HUNT2 
(1995–1997) and HUNT3 (2006–2008) surveys.
Main outcome measure Chronic LBP, defined as LBP 
persisting at least 3 months continuously during the past 
year.
Participants Among individuals aged 19–55 years 
without LBP in HUNT2, a data set was generated including 
1685 cases with LBP in HUNT3 and 3137 controls without 
LBP.
Methods Blood samples from the participants collected 
in HUNT2 were analysed for serum 25-hydroxyvitamin 
D (25(OH)D) level. Associations with LBP in HUNT3 were 
evaluated by unconditional logistic regression analysis 
with adjustment for age, sex, work status, physical activity 
at work and in leisure time, education, smoking, and body 
mass index.
Results No association between vitamin D status and 
risk of chronic LBP was found in the total data set (OR 
per 10 nmol/L 25(OH)D=1.01, 95% CI 0.97 to 1.06) or 
in individuals with blood samples collected in summer/
autumn (OR per 10 nmol/L 25(OH)D=0.99, 95% CI 0.93 
to 1.06). For blood samples drawn in winter/spring, 
associations differed significantly between women and 
men (p=0.004). Among women a positive association 
was seen (OR per 10 nmol/L 25(OH)D=1.11, 95% CI 1.02 
to 1.20), but among men no significant association was 
observed (OR per 10 nmol/L 25(OH)D=0.90, 95% CI 0.81 
to 1.01).
Conclusions Overall, no association between vitamin D 
status and risk of LBP was demonstrated. The association 
suggested in women for the winter/spring season cannot 
be regarded as established.
InTRODuCTIOn
Low back pain (LBP) is one of the most 
common musculoskeletal disorders and 
often leads to sick leave and a high degree 
of disability with substantial costs for society.1 
The causes of non-specific LBP are not suffi-
ciently understood.2 
Vitamin D is required for absorption of 
calcium from the intestines, and vitamin 
D has shown positive health effects on the 
muscle and skeletal system.3 Skeletal muscles 
have vitamin D receptors and may require 
vitamin D for maximum function.4 Associa-
tions between vitamin D deficiency and inci-
dence of chronic pain have been suggested 
in various studies, but the evidence is not 
conclusive.5 Some studies have found associa-
tions between vitamin D deficiency and occur-
rence of non-specific musculoskeletal pain in 
patient materials6 and in population-based 
data sets.7 A meta-analysis8 concluded that 
vitamin D supplementation can decrease 
pain scores in chronic widespread pain.
Very few population-based studies have 
been carried out regarding associations 
between vitamin D status and occurrence 
of back pain,9 in particular with a prospec-
tive design. Studies of associations between 
Is there an association between vitamin 
D status and risk of chronic low back 
pain? A nested case–control analysis in 
the Nord-Trøndelag Health Study
Ingrid Heuch,1 Ivar Heuch,2 Knut Hagen,3,4 Xiao-Mei Mai,5 Arnulf Langhammer,5 
John-Anker Zwart1,6
To cite: Heuch I, Heuch I, 
Hagen K, et al.  Is there 
an association between 
vitamin D status and risk of 
chronic low back pain? A 
nested case–control analysis 
in the Nord-Trøndelag 
Health Study. BMJ Open 
2017;7:e018521. doi:10.1136/
bmjopen-2017-018521
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
018521).
Received 7 July 2017
Revised 4 October 2017
Accepted 9 October 2017
For numbered affiliations see 
end of article.
Correspondence to
Dr Ingrid Heuch;  
 ingrid. heuch@ ous- hf. no
Research
Strengths and limitations of this study
 ► The study is prospective and the medical condition 
considered, chronic low back pain at end of follow-
up, cannot have influenced vitamin D status at 
baseline.
 ► Season of blood sample collection for analysis of 
serum 25-hydroxyvitamin D is taken into account in 
the analysis.
 ► Vitamin D and back pain status were not registered 
in the intermediate period between baseline and end 
of follow-up.
 ► The mean length of time between blood sample 
collection and assessment of final back pain status 
was 11 years, and individual vitamin D status may 
have changed considerably in the meantime.
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vitamin D status and back pain have mostly been based 
on relatively small data sets involving patients, with some 
studies10–14 suggesting an association between low vitamin 
D levels and back pain, while other studies15–17 were 
unable to demonstrate any relationships. A cross-sec-
tional study among schoolchildren also indicated such an 
association.18 A small randomised clinical trial of patients 
with chronic LBP failed to show any effect of vitamin D 
supplementation.19
Potential associations between vitamin D deficiency 
and LBP have partly been ascribed to osteomalacia,12 
with an accumulation of osteoid because of defective 
mineralisation. Poor muscle strength induced by vitamin 
D deficiency3 may also affect the experience of LBP. It is 
not certain, however, whether these factors play any role 
considering the incidence of LBP at the population level.
Only prospective studies can show whether vitamin D 
levels affect the subsequent risk of experiencing LBP. It 
is possible that back pain conversely can affect vitamin D 
status,11 perhaps through modified behaviour influencing 
exposure to sunlight or through nutritional factors, and 
for this reason it is essential to base conclusions on results 
from prospective studies. It is important to carry out adjust-
ment for potential confounders such as obesity, which is 
related to both vitamin D levels and to risk of LBP.20–22 
Vitamin D levels are higher after sun exposure, with the 
prevalence of vitamin D deficiency varying seasonally,23 
so associations should also be assessed separately for the 
summer/autumn and winter/spring seasons.
This study will investigate whether an association can 
be established between vitamin D status and risk of LBP 
in a case–control study nested in a Norwegian cohort. 
Vitamin D status is based on measurement of the major 
circulating metabolite 25-hydroxyvitamin D (25(OH)
D).24 The importance of seasonality for blood sample 
collection for vitamin D measurement will be explored.
MeThODS
Participants
The present work is based on information from the 
Nord-Trøndelag Health Study (HUNT). From 1995 to 
1997, the large health survey HUNT2 was conducted in 
Nord-Trøndelag county in Norway. The entire adult popu-
lation received a health questionnaire and participants 
underwent a clinical examination, including measure-
ments of body weight and height.25 In particular, each 
participant provided information on the questionnaire 
showing whether he or she had experienced chronic 
LBP during the preceding 12-month period, defined as 
LBP lasting at least 3 months continuously in that period. 
Blood samples were drawn at the clinical examination. In 
the HUNT3 survey, conducted in 2006–2008 in the same 
county with a corresponding target population, similar 
questionnaires were distributed.25 Information about 
residence status was supplied by national registries and 
linked by use of the unique Norwegian personal identifi-
cation numbers.
A nested case–control study was conducted using 
prospective data from HUNT2 regarded as baseline 
and HUNT3 regarded as follow-up, including 4822 indi-
viduals in the age range 19–55 years when attending 
HUNT2. Vitamin D status was assessed on the basis of 
blood samples from the participants collected in HUNT2 
in 1995–1997, but the actual measurements were only 
carried out later. Participants belonged to three different 
subsamples. The first and second subsamples consisted 
of random samples from HUNT2 and were established 
in connection with previous studies of the association 
between vitamin D and asthma and lung function,26 27 but 
in the current study all individuals with LBP in HUNT2 
were excluded. The first subsample was analysed for 
25(OH)D in 2010, and included altogether 1492 persons 
(figure 1), comprising 247 cases (individuals with LBP 
in HUNT3) and 1245 controls (individuals without LBP 
in HUNT3). The second subsample with analysis date 
for 25(OH)D in 2015 included a total of 2051 persons 
(figure 1), comprising 343 cases and 1708 controls. The 
third subsample had measurements of 25(OH)D carried 
out in 2014/2015 and consisted of 1279 persons without 
LBP in HUNT2. Of these, a total of 1095 cases were 
selected at random among persons suffering from LBP in 
HUNT3 and 184 controls were randomly selected among 
persons without LBP in HUNT3 (figure 1). The third 
subsample was solely established for the current nested 
case–control study. None of the individuals included in 
this study had missing values for any covariate considered.
The original plan was that the nested case–control study 
would consist of the combined first and third subsamples 
only, and the size of the third subsample was adapted to 
power requirements in this data set. The second subsa-
mple only became available at a later stage.
exposure
Blood samples collected in HUNT2 were stored at 
−70°C until analysis. The level of 25(OH)D in serum was 
measured in the years 2010 and in 2014/2015 by chemi-
luminescent immunoassay methodology, using Liaison 
25-OH Vitamin D Total Assay (DiaSorin, Saluggia, Italy). 
The method has an intra-assay coefficient of variation 
of 4% and an interassay coefficient of variation of 8%. 
Another kit from DiaSorin was used from 2014. A total of 
118 samples with measurements available from 2010 were 
reanalysed in 2015 with the new kit. After exclusion of two 
outliers, a conversion factor for measurements from 2010 
to new values from 2014/2015 was established by Passing 
and Bablok regression.28
Serum 25(OH)D levels were classified into 
three groups, <50.0 nmol/L, 50.0–74.9 nmol/L 
and ≥75.0 nmol/L, which are widely used categories 
in studies of vitamin D levels. Values <50.0 nmol/L are 
usually regarded as representing vitamin D deficiency.29
Covariate assessment
Baseline age was categorised into 10-year intervals. Four 
categories of work status were defined, the first comprising 
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Figure 1 Flow chart showing participants for statistical analysis in the nested case–control study. 25(OH)D, 25-hydroxyvitamin 
D; HUNT, Nord-Trøndelag Health Study; LBP, low back pain. 
people being employed or carrying out professional 
work. The second category included those temporarily 
out of work, students and individuals in military service. 
The third category included pensioners and people 
receiving social security support, and the fourth category 
represented women occupied full time with housework. 
Those currently working supplied information about 
physical activity at work,30 in four categories representing 
substantially sedentary work, work involving extensive 
walking, work leading to both walking and lifting, and 
work involving particularly strenuous activities. For phys-
ical activity in leisure time, including going to work, one 
category included those engaged in light activity only or 
hard physical activity (leading to sweating or being out of 
breath) <1 hour per week.31 Other categories represented 
hard physical activity 1–2 and ≥3 hours per week.
Education was grouped according to duration as ≤9, 
10–12 or ≥13 years. Categories of cigarette smoking repre-
sented current daily smoking, previous daily smoking and 
never daily smoking. Body mass index (BMI), defined as 
weight/height2 and computed in kg/m2, was subdivided 
into three groups: <25, 25–29.9 and ≥30.
Season of blood sample collection was categorised 
as either the summer/autumn season (June through 
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Table 1 Number of individuals by age, sex, vitamin D 
status and case–control status
Cases, with LBP 
at end of follow-
up
Controls, 
without LBP at 
end of follow-up
n Per cent n Per cent
Age groups (years)
  19–29 246 15 504 16
  30–39 492 29 951 30
  40–49 687 41 1191 38
  50–55 260 15 491 16
Sex
  Female 1043 62 1677 54
  Male 642 38 1460 47
25(OH)D (nmol/L)
  <50.0 925 55 1689 54
  50.0–74.9 619 37 1126 36
  ≥75.0 141 8 322 10
25(OH)D, 25-hydroxyvitamin D; LBP, low back pain.
Table 2 Descriptive statistics of 25(OH)D level by case–control status
Cases, with LBP at end of follow-up
















  All seasons 1685 49.4 18.2 47.9 3137 50.0 19.1 48.0
  Summer/autumn 773 54.1 18.4 52.0 1424 56.7 19.0 55.2
  Winter/spring 912 45.4 17.0 43.8 1713 44.4 17.4 41.9
Women
  All seasons 1043 50.2 18.6 48.9 1677 50.5 19.0 49.0
  Summer/autumn 480 53.8 18.7 52.9 784 56.2 18.7 54.4
  Winter/spring 563 47.1 17.9 45.9 893 45.4 17.9 43.0
Men
  All seasons 642 48.0 17.4 45.8 1460 49.4 19.3 46.6
  Summer/autumn 293 54.5 18.0 51.3 640 57.4 19.4 56.1
  Winter/spring 349 42.6 14.9 40.8 820 43.2 16.7 40.4
25(OH)D, 25-hydroxyvitamin D; LBP, low back pain.
November) or the winter/spring season (December 
through May). This subdivision gives a marked difference 
in vitamin D deficiency between 6 months’ periods.23
Statistical methods
Associations between 25(OH)D levels in serum and 
risk of chronic LBP were assessed by unconditional 
logistic regression analysis with adjustment for potential 
confounders. Analyses were performed separately with 
25(OH)D levels as categorical and continuous variables. 
All other variables were considered categorical. First, 
adjustments were carried out for age and sex and a factor 
indicating which subsample each individual belonged to. 
Additional adjustments for work status, physical activity at 
work and in leisure time, education, smoking, BMI, and 
season of blood sample collection were then introduced. 
Separate tests were performed for interaction between 
continuous 25(OH)D level and all variables adjusted 
for. Linearity in the association with continuous 25(OH)
D level was tested for by adding a quadratic term to the 
statistical model. All statistical analyses were carried out 
using IBM SPSS V.23.
Separate analyses were limited to participants who had 
the blood samples drawn in the summer/autumn season 
and the winter/spring season.
ReSulTS
The age distribution was quite similar among cases and 
controls (table 1). The percentage of women was higher 
among cases than among controls. Within the three 
separate groups of serum 25(OH)D levels categorised 
as <50.0 nmol/L, 50.0–74.9 nmol/L and ≥75.0 nmol/L, 
the percentage of persons with and without LBP at end of 
follow-up was almost the same among cases and controls 
(table 1).
In the total data set, the mean serum 25(OH)D levels 
were quite similar among cases and controls (table 2). 
Both in women and men the serum 25(OH)D levels were 
higher in the summer/autumn than in the winter/spring 
season among cases and controls.
In the overall data set no association was found between 
vitamin D status and risk of LBP, neither with adjustment 
for age, sex and subsample nor with complete adjustment 
(OR per 10 nmol/L 25(OH)D=1.01, 95% CI 0.97 to 1.06) 
(table 3). No significant interaction was found, but the 
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Table 3 Associations between vitamin D status and risk of chronic LBP
With adjustment for age, sex and 
subsample With complete adjustment*
OR (95% CI) p OR (95% CI) p
Total data set
25(OH)D (nmol/L) 0.64† 0.97†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 0.94 (0.80 to 1.11) 1.01 (0.85 to 1.20)
  ≥75.0 0.90 (0.68 to 1.18) 0.98 (0.73 to 1.31)
  Per 10 nmol/L 0.99 (0.95 to 1.03) 0.59 1.01 (0.97 to 1.06) 0.59
Women
25(OH)D (nmol/L) 0.54† 0.27†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 1.09 (0.88 to 1.36) 1.20 (0.96 to 1.51)
  ≥75.0 0.91 (0.64 to 1.30) 1.05 (0.72 to 1.52)
  Per 10 nmol/L 1.02 (0.97 to 1.08) 0.48 1.06 (1.00 to 1.12) 0.054
Men
25(OH)D (nmol/L) 0.10† 0.16†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 0.75 (0.57 to 0.98) 0.76 (0.57 to 1.01)
  ≥75.0 0.90 (0.58 to 1.39) 0.88 (0.55 to 1.41)
  Per 10 nmol/L 0.94 (0.88 to 1.01) 0.10 0.94 (0.88 to 1.02) 0.13
*Adjustment for age, sex, work status, physical activity at work and in leisure time, education, smoking, body mass index, 
subsample, and season of blood sample collection.
†For categorical effect.
25(OH)D, 25-hydroxyvitamin D; LBP, low back pain.
interaction with sex was marginally significant (p=0.06). 
A weak positive association was suggested among women, 
although the estimated relation among men was in the 
opposite direction (table 3). Results did not differ signifi-
cantly between subsamples.
Separate analyses of the association between vitamin D 
status and risk of LBP by season of blood sample collec-
tion revealed no effect in either sex in the summer/
autumn season (table 4). However, in the winter/spring 
season, associations differed significantly between women 
and men (p=0.004). In women a significant positive asso-
ciation was observed (OR per 10 nmol/L 25(OH)D=1.11, 
95% CI 1.02 to 1.20) (table 4). In men the estimated asso-
ciation was negative (OR per 10 nmol/L 25(OH)D=0.90, 
95% CI 0.81 to 1.01) but did not reach statistical signifi-
cance. Considering the different OR values from the cate-
gorical analyses, a consistent trend was suggested in each 
sex.
No significant deviations from linearity were observed 
in the relationships with 25(OH)D considered as a contin-
uous variable.
DISCuSSIOn
The association between vitamin D status and chronic 
LBP was examined in a case–control study nested in a 
population-based follow-up of a Norwegian cohort. No 
association between vitamin D status and risk of LBP 
was found overall. For measurements in the winter/
spring season, associations differed significantly between 
women and men. Among women a positive association 
was seen, but among men no significant association was 
observed.
A strength of the study is that the overwhelming 
majority of participants belonged to a homogeneous 
ethnic group.32 Information was available on potential 
confounders, which made it possible to carry out accurate 
adjustments. The risk factor considered is represented by 
the vitamin D status measured in blood samples drawn at 
the clinical examination in HUNT2. However, the blood 
samples were stored for many years at low temperature, 
and the measurements of serum 25(OH)D levels were 
carried out in 2010 or in 2014/2015. Despite attempts 
to standardise the measurements, use of different instru-
ments in the two periods may have led to minor system-
atic deviations in the 25(OH)D levels. To some extent, 
this was accounted for by adjusting all statistical analyses 
for subsample. This procedure was also essential in view 
of the different sampling procedures applied to establish 
the subsamples. The Liaison immunoassay method may 
still underestimate true 25(OH)D levels,33 and a direct 
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Table 4 Associations between vitamin D status and risk of chronic LBP by season of blood sample collection*
Summer/autumn Winter/spring
OR (95% CI) p OR (95% CI) p
Total data set
25(OH)D (nmol/L) 0.87† 0.79†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 0.93 (0.72 to 1.20) 1.08 (0.85 to 1.38)
  ≥75.0 0.96 (0.66 to 1.39) 0.96 (0.58 to 1.58)
  Per 10 nmol/L 0.99 (0.93 to 1.06) 0.78 1.03 (0.97 to 1.10) 0.37
Women
25(OH)D (nmol/L) 0.56† 0.27†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 1.13 (0.81 to 1.57) 1.26 (0.92 to 1.73)
  ≥75.0 0.89 (0.53 to 1.47) 1.34 (0.76 to 2.35)
  Per 10 nmol/L 1.00 (0.92 to 1.09) 0.94 1.11 (1.02 to 1.20) 0.012
Men
  25(OH)D (nmol/L) 0.15† 0.20†
  <50.0 1.00 (Reference) 1.00 (Reference)
  50.0–74.9 0.70 (0.46 to 1.05) 0.84 (0.56 to 1.27)
  ≥75.0 1.01 (0.58 to 1.76) 0.37 (0.12 to 1.17)
  Per 10 nmol/L 0.97 (0.88 to 1.08) 0.58 0.90 (0.81 to 1.01) 0.08
*Adjustment for age, sex, work status, physical activity at work and in leisure time, education, smoking, body mass index, and 
subsample.
†For categorical effect.
25(OH)D, 25-hydroxyvitamin D; LBP, low back pain.
comparison with values found by other methods may not 
be justified.34
A limitation is the lack of information about back pain 
occurring at other times in the 11-year follow-up interval 
between HUNT2 and HUNT3. The case definition only 
refers to the last year before collection of information 
in HUNT3. Thus all cases must have experienced inci-
dent chronic LBP during follow-up but so may some of 
the controls in the intervening period if they later recov-
ered. Any real association between vitamin D status and 
LBP should be present anyhow but may be more difficult 
to detect. Furthermore, the extent of back pain was not 
characterised by the participants.
Another potential problem is the relatively long period 
between collection of information about risk factors and 
the recording of LBP status. In view of the weaker associ-
ations seen between 25(OH)D levels and mortality and 
cancer risk in prospective studies with longer follow-pe-
riods, it has been suggested that 25(OH)D levels should 
be measured at regular intervals in prospective studies, 
perhaps every 2–4 years.35 Such information was not avail-
able in the present study. However, vitamin D levels have 
been shown to be relatively stable over periods as long as 
14 years in the Norwegian population,36 and large data 
sets in other countries have shown a definite degree of 
stability over somewhat shorter periods.37 38 In data with 
measurements from the HUNT2 survey, low 25(OH)D 
levels showed a clear association with all-cause mortality in 
a prospective study with a median follow-up time of 18.5 
years.39 Thus potential relationships between 25(OH)
D levels and disease should still persist in a study such 
as the current one with 11 years of follow-up, although 
associations may be attenuated. The state of relevant 
confounders may also change during a long follow-up. An 
alternative to the design used here would be a cross-sec-
tional case–control study based on both 25(OH)D levels 
and reports of chronic LBP from the HUNT2 survey. 
Problems concerning 25(OH)D levels changing over 
time would be eliminated, but it would not be possible to 
rule out an influence of disease on 25(OH)D status.
There are few population-based studies of the relation-
ships between vitamin D status and LBP.9 Some studies 
have investigated such relationships among patients,11 13 16 
but population-based studies of risk of LBP with a prospec-
tive design have been lacking. The present study is to our 
knowledge the only prospective study of the association 
between vitamin D status and risk of LBP.
In cross-sectional population-based studies, an asso-
ciation between low level of 25(OH)D and prevalence 
of back pain has been found in older women9 and in 
schoolchildren.18 Some case–control studies have shown 
an association between low levels of vitamin D and occur-
rence of back pain,12 14 but others do not support an asso-
ciation.15 17 In a recent small Swedish case–control study, 
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no difference in vitamin D levels could be established 
between participants with chronic LBP and matched 
controls.17 This is consistent with the overall results found 
in our study.
Among women with blood samples drawn in the winter/
spring season, we found that high levels of vitamin D were 
associated with an increased risk of LBP, which is the 
opposite of what was initially hypothesised. In a Danish 
cross-sectional study of patients with LBP, an association 
in the same direction was found, and normal levels of 
vitamin D, as opposed to vitamin D deficiency, were asso-
ciated with more Modic changes in the lumbar vertebral 
end plates as seen on MRI.16
An association between vitamin D deficiency and 
adiposity has been found in several studies.21 This was also 
confirmed in a cross-sectional study in the HUNT popu-
lation.23 In a prospective study using data from HUNT2 
and HUNT3, overweight and obesity were found to be 
associated with a predisposition to chronic LBP.22 This 
suggests that BMI could be a confounder in the associ-
ation with 25(OH)D. However, our complete analyses 
included adjustment for BMI, and it is not to be expected 
that any substantial relationship should remain because 
of the association with adiposity.
In view of the seasonal variation in sun exposure, it is 
important to look at the time when blood samples are 
collected to define vitamin D deficiency.40 Thus in a study 
of bone mineral density, the summer season was found 
to be the best period to determine the serum 25(OH)
D level.41 This contrasts with our results, with a positive 
association between LBP and vitamin D status observed 
in the winter/spring season for women only. Elevated 
levels of 25(OH)D may be harmful in other respects.42 
In a study of mortality among hospitalised patients, a 
U-shaped relationship was found, with both low and 
high values of 25(OH)D associated with increased 
mortality.42 43 However, the 25(OH)D levels had to be 
considerably above the typical values in the present study 
to be associated with higher mortality and a causal rela-
tionship was not inferred, so such effects at the upper end 
of the range for 25(OH)D are hardly relevant here. False 
U-shaped relationships between 25(OH)D levels and 
health problems may easily appear when individuals with 
poor health have only recently started using vitamin D 
supplement and are thus essentially misclassified.44
Gender and sex hormone levels are important variables 
that can influence a possible effect of vitamin D in rheu-
matic diseases.45 In a Danish population receiving ultra-
violet B treatment, the decline in 25(OH)D varied over 
time between sexes, with women maintaining a greater 
half-life of 25(OH)D.46 It is not evident, however, how 
such differences can explain the sex contrast seen in the 
present study in the association with risk of LBP.
Measurements of 25(OH)D levels made during the 
winter/spring season may possibly capture variability of 
vitamin D in a better way, because vitamin D values in 
winter are not so dependent on sunlight exposure. It is 
possible, however, that women tending to report LBP in 
this population are particularly health-conscious and use 
more vitamin D supplements during the winter/spring 
season, creating a false-positive association. Cod liver oil 
supplement has traditionally represented a major source 
of vitamin D in Norway,47 with about 35% of both the 
male and female populations using such supplement in 
the 1990s.48 Whole-year usage among women is associated 
with poor perceived health but is otherwise associated 
with a healthy diet,47 suggesting that use of supplements 
is not in general matched to the vitamin D needs.47 In any 
case, the significant relationship observed among women 
may be spurious due to the multiple statistical tests 
carried out. Thus this association cannot yet be regarded 
as causal.
A basic biological relationship between vitamin D 
status and risk of LBP would be expected to be similar 
in different populations. Unless the lack of overall asso-
ciation seen in the present study represents a chance 
finding, the result should also apply to other popula-
tions. However, the population distribution of vitamin D 
status may vary substantially between countries because of 
differences in sunlight exposure and dietary conditions. 
Thus it is not obvious that our main result can be gener-
alised to other widely different populations, and further 
studies are still called for.
COnCluSIOnS
In this population-based, nested case–control study, no 
overall association between vitamin D status and risk 
of LBP was found. The positive association observed in 
women with blood samples drawn in the winter/spring 
season needs confirmation from other studies.
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